66-year-old female with severe shoulder pain

66-year-old female with severe shoulder pain. Coronal MR images show definite small AIGM (blue arrows), corresponding to diagnostic confidence of 4. In addition, there is high-grade glenohumeral osteoarthrosis, as well as small joint effusion (purple arrow).


May 7, 2024 — The Magna Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual Meeting showed a high prevalence (89%) of accessory infraglenoid muscle (AIGM) in patients with teres minor fatty infiltration (TMFI)—compared to those without (30%). Additionally, within the TMFI cohort, many AIGM abutted the axillary nerve with concomitant axillary neuropathy.

“These results stress the importance of looking for AIGM in the setting of TMFI, as TMFI on preoperative MRI has been associated with poor postsurgical outcomes,” said Jennifer Padwal, MD, from Stanford University Medical Center in California. “And the presence of AIGM on shoulder MRI could negate the need for additional imaging to evaluate the cause of TMFI.”

Padwal et al.’s institutional review of all shoulder MRIs yielded 100 patients with documented TMFI (76 men, 24 women; mean age, 58.6 years). For comparison, a respective sample of 100 shoulder MRIs in patients without TMFI (53 men, 47 women; mean age, 56.4 years) was obtained. All scans were consensus evaluated by two radiologists (one musculoskeletal attending with 25 years of experience, as well as a 4th-year radiology resident) for an AIGM with diagnostic confidence, noting muscle origin and insertion. In patients with TMFI, the distance between the AIGM and axillary nerve was measured, documenting any abnormal axillary nerve signal. TMFI was then graded via Goutallier classification, while the presence of atrophy and/or edema was noted.

Ultimately, in the ARRS Annual Meeting Magna Cum Laude Online Poster, TMFI was grade 1 in 33%, grade 2 in 32%, grade 3 in 13%, and grade 4 in 14%, with intramuscular edema in 33 and atrophy in 21 patients. AIGM was seen in 89/100 patients with TMFI; 30/100 patients without TMFI. In all cases, the AIGM originated from the inferior glenoid neck and inserted onto the humeral neck/proximal humeral diaphysis. The inferior margin of the AIGM in patients with TMFI touched the axillary nerve in 39 (46%), with abnormal signal in 23 (27%) patients.  

For more information: www.arrs.org

 

Find more ARRS24 conference coverage here


Related Content

News | Radiology Education

Jan. 22, 2026—The American Roentgen Ray Society (ARRS) will host a live virtual symposium, "Medical Imaging for ...

Time January 28, 2026
arrow
News | Radiology Imaging

Jan.26, 2026 — SimonMed Imaging has unveiled an updated brand and the launch of SimonMed Longevity, a new division ...

Time January 27, 2026
arrow
News | Computed Tomography (CT)

Jan. 21, 2026 — Aidoc recently announced that the U.S. Food and Drug Administration (FDA) cleared the industry's first ...

Time January 23, 2026
arrow
News | Point-of-Care Ultrasound (POCUS)

Jan. 22, 2026 — Qure.ai has received a grant from the Gates Foundation to develop a large open-source multi-modal ...

Time January 23, 2026
arrow
News | PACS

Jan. 21, 2026 — Fujifilm Healthcare Americas Corp. and Voicebrook, Inc. have announced a strategic partnership to ...

Time January 22, 2026
arrow
News | Radiology Education

Jan. 20, 2026 — The American Society of Radiologic Technicians (ASRT) Foundation has named ASRT member Danielle McDonagh ...

Time January 20, 2026
arrow
News | Radiology Business

Jan. 7, 2026 — RadNet, Inc., a provider of high-quality, cost-effective outpatient diagnostic imaging services and ...

Time January 13, 2026
arrow
News | X-Ray

Dec. 31, 2025 – Carestream Health, Inc. has completed the separation of the company into two geographically focused ...

Time January 08, 2026
arrow
News | Radiology Business

Jan. 6, 2026 — DirectMed Imaging, a portfolio company of Frazier Healthcare Partners, has acquired Tri-Imaging Solutions ...

Time January 06, 2026
arrow
News | Stroke

Dec. 12, 2025 — Hyperfine, Inc. has announced that it has received FDA clearance for a new multi-direction diffusion ...

Time December 15, 2025
arrow
Subscribe Now